ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Rocket Pharmaceuticals receives FDA fast track designation for RP-L401 gene therapy for infantile malignant osteopetrosis
September 01, 2020Rocket Pharmaceuticals, a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to RP-L401..
Pharma Sources Insight January 2025
